1. Home
  2. Analysis
  3. Daptomycin
  4. Organising-pneumonia

Daptomycin and Organising pneumonia - a phase IV clinical study of FDA data

Summary:

Organising pneumonia is reported as a side effect among people who take Daptomycin (daptomycin), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Lovenox, and have Staphylococcal infection.

The phase IV clinical study analyzes which people have Organising pneumonia when taking Daptomycin. It is created by eHealthMe based on reports of 7,865 people who have side effects when taking Daptomycin from the FDA, and is updated regularly.

What is Daptomycin?

Daptomycin has active ingredients of daptomycin. eHealthMe is studying from 7,879 Daptomycin users. Check the latest studies of Daptomycin.

What is Organising pneumonia?

Organising pneumonia (pathologically by the presence in the distal air spaces of buds of granulation tissue) is found to be associated with 438 drugs and 490 conditions by eHealthMe. Check the latest studies of Organising pneumonia.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

7,865 people reported to have side effects when taking Daptomycin.
Among them, 21 people (0.27%) have Organising pneumonia.

Could Daptomycin cause Organising pneumonia?

Among these 21 people:

How long have people been on Daptomycin when they have Organising pneumonia? *

  • < 1 month: 56.25 %
  • 1 - 6 months: 43.75 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Organising pneumonia when taking Daptomycin? *

  • female: 15 %
  • male: 85 %

What is the age of people who have Organising pneumonia when taking Daptomycin? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 5 %
  • 40-49: 5 %
  • 50-59: 15 %
  • 60+: 75 %

What are other drugs people take besides Daptomycin? *

  1. Lovenox: 3 people, 14.29%
  2. Vancomycin: 2 people, 9.52%
  3. Veletri: 2 people, 9.52%
  4. Flagyl: 1 person, 4.76%
  5. Atrovent: 1 person, 4.76%
  6. Augmentin: 1 person, 4.76%
  7. Bactrim: 1 person, 4.76%
  8. Cancidas: 1 person, 4.76%
  9. Candesartan Cilexetil: 1 person, 4.76%
  10. Cordarone: 1 person, 4.76%

What are other side effects people have besides Organising pneumonia? *

  1. Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 6 people, 28.57%
  2. Diffuse Alveolar Damage (common manifestation of drug-induced lung injury): 5 people, 23.81%
  3. Interstitial Lung Disease: 5 people, 23.81%
  4. Ards (Acute Respiratory Distress Syndrome) (sudden failure of the respiratory (breathing) system): 4 people, 19.05%
  5. Weight Decreased: 2 people, 9.52%
  6. Lung Infiltration (a substance that normally includes fluid, inflammatory exudates or cells that fill a region of lung): 2 people, 9.52%
  7. Cardio-Respiratory Arrest (sudden dysfunction of heart and lungs): 2 people, 9.52%
  8. Cellulitis (infection under the skin): 2 people, 9.52%
  9. Dyspnea (difficult or laboured breathing): 2 people, 9.52%
  10. Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs): 2 people, 9.52%

What are the existing conditions these people have? *

  1. Staphylococcal Infection (an infection with staphylococcus bacteria): 6 people, 28.57%
  2. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 5 people, 23.81%
  3. Endocarditis (inflammation in heart muscle): 3 people, 14.29%
  4. Cardiac Failure: 2 people, 9.52%
  5. Cellulitis (infection under the skin): 2 people, 9.52%
  6. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 2 people, 9.52%
  7. Pain: 2 people, 9.52%
  8. Fluid Overload (too much fluid in the blood): 2 people, 9.52%
  9. Enterococcal Infection: 1 person, 4.76%
  10. Cardiac Valve Abscess (pus containing infection of heart valve): 1 person, 4.76%

* Approximation only. Some reports may have incomplete information.

Do you take Daptomycin and have Organising pneumonia?

- Check whether Organising pneumonia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Daptomycin:

Organising pneumonia treatments and more:

How severe was Organising pneumonia and when was it recovered:

Expand to all the drugs that have ingredients of daptomycin:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Daptomycin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Organising pneumonia:

Browse all the conditions that are associated with Organising pneumonia:

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on daptomycin (the active ingredients of Daptomycin) and Daptomycin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.